Результати пошуку - Rajneesh Nath

  • Показ 1 - 12 результатів із 12
Уточнити результати
  1. 1
    Universal: An Allogeneic First-in-Human Study of the Anti-Bcma ALLO-715 and the Anti-CD52 ALLO-647 in Relapsed/Refractory Multiple Myeloma

    Universal: An Allogeneic First-in-Human Study of the Anti-Bcma ALLO-715 and the Anti-CD52 ALLO-647 in Relapsed/Refractory Multiple Myeloma за авторством Sham Mailankody, Jeffrey Matous, Michaela Liedtke, Surbhi Sidana, Shahbaz A. Malik, Rajneesh Nath, Olalekan O. Oluwole, Erin E. Karski, Wade Lovelace, Xiangdong Zhou, Srinand Ponnathapura Nandakumar, Arun Balakumaran, Parameswaran Hari

    Опубліковано 2020
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  2. 2
    PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study

    PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study за авторством Renata Ferrarotto, Paul Swiecicki, Dan P. Zandberg, Robert A. Baiocchi, Robert Wesolowski, Cristina P. Rodriguez, Meredith McKean, Hyunseok Kang, Varun Monga, Rajneesh Nath, Neil Palmisiano, Naveen Babbar, William Sun, Glenn J. Hanna

    Опубліковано 2023
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    Reduced-Intensity Conditioning for Unrelated Donor Progenitor Cell Transplantation: Long-Term Follow-Up of the First 285 Reported to the National Marrow Donor Program

    Reduced-Intensity Conditioning for Unrelated Donor Progenitor Cell Transplantation: Long-Term Follow-Up of the First 285 Reported to the National Marrow Donor Program за авторством Sergio Giralt, Brent R. Logan, Douglas Rizzo, Mei-Jie Zhang, Karen K. Ballen, Christos Emmanouilides, Rajneesh Nath, Pablo Parker, David Porter, Brenda M. Sandmaier, Edmund K. Waller, Juliet N. Barker, Steven Z. Pavletic, Daniel J. Weisdorf

    Опубліковано 2007
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    Expression of <scp>CD</scp>25 independently predicts early treatment failure of acute myeloid leukaemia (<scp>AML</scp>)

    Expression of <scp>CD</scp>25 independently predicts early treatment failure of acute myeloid leukaemia (<scp>AML</scp>) за авторством Jan Černý, Hongbo Yu, Muthalagu Ramanathan, Glen Raffel, William Walsh, Natasha Fortier, Lindsey Shanahan, Elizabeth O'Rourke, Josef Bednařík, Bruce Barton, Aimee Kroll‐Desrosiers, Suyang Hao, Bruce A. Woda, Lloyd Hutchinson, Andrew M. Evens, Alan G. Rosmarin, Rajneesh Nath

    Опубліковано 2012
    Отримати повний текст Отримати повний текст
    Carta
    Додати у Вибране
    Збережено в:
  5. 5
    Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study

    Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study за авторством Roy F. Chemaly, Lynn El Haddad, Drew J. Winston, Scott D. Rowley, Kathleen M Mulane, Pranatharthi Chandrasekar, Robin K. Avery, Parameswaran Hari, Karl S. Peggs, Deepali Kumar, Rajneesh Nath, Per Ljungman, Sherif B. Mossad, Sanjeet Dadwal, Ted Blanchard, Dimpy P. Shah, Ying Jiang, Ella Ariza‐Heredia

    Опубліковано 2020
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Universal Updated Phase 1 Data Validates the Feasibility of Allogeneic Anti-BCMA ALLO-715 Therapy for Relapsed/Refractory Multiple Myeloma

    Universal Updated Phase 1 Data Validates the Feasibility of Allogeneic Anti-BCMA ALLO-715 Therapy for Relapsed/Refractory Multiple Myeloma за авторством Sham Mailankody, Michaela Liedtke, Surbhi Sidana, Jeffrey Matous, Saurabh Chhabra, Olalekan O. Oluwole, Shahbaz A. Malik, Shaji Kumar, Rajneesh Nath, Faiz Anwer, José C. Cruz, Sundar Jagannath, Myo Htut, Noopur Raje, David S. Siegel, Erin E. Karski, Wade Lovelace, Afrodite Lourbakos, Srinand Ponnathapura Nandakumar, Arun Balakumaran, Parameswaran Hari

    Опубліковано 2021
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    Lisocabtagene Maraleucel (liso-cel) in R/R CLL/SLL: 24-Month Median Follow-up of TRANSCEND CLL 004

    Lisocabtagene Maraleucel (liso-cel) in R/R CLL/SLL: 24-Month Median Follow-up of TRANSCEND CLL 004 за авторством Tanya Siddiqi, David G. Maloney, Saad S. Kenderian, Danielle M. Brander, Kathleen A. Dorritie, Jacob D. Soumerai, Peter A. Riedell, Nirav N. Shah, Rajneesh Nath, Bita Fakhri, Deborah M. Stephens, Shuo Ma, Tatyana Feldman, Scott R. Solomon, Stephen J. Schuster, Serena K. Perna, Sherilyn A. Tuazon, San-San Ou, Neha Rane, William G. Wierda

    Опубліковано 2023
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study

    Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study за авторством Alison R. Sehgal, Daanish Hoda, Peter A. Riedell, Nilanjan Ghosh, Mehdi Hamadani, Gerhard Hildebrandt, John E. Godwin, Patrick M. Reagan, Nina D. Wagner‐Johnston, James Essell, Rajneesh Nath, Scott R. Solomon, Rebecca Champion, Edward Licitra, Suzanne Fanning, Neel K. Gupta, Victor A. Chow, Brenda Yuan, Zhi Yang, K. OGASAWARA, Jerill Thorpe, Leo I. Gordon

    Опубліковано 2025
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis

    Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis за авторством Shaji Kumar, Mei-Jie Zhang, Peigang Li, Angela Dispenzieri, Giuseppe Milone, Sagar Lonial, Amrita Krishnan, Ângelo Maiolino, Baldeep Wirk, Brendan M. Weiss, César O. Freytes, Dan T. Vogl, David H. Vesole, Hillard M. Lazarus, Kenneth R. Meehan, Mehdi Hamadani, Michael Lill, Natalie S. Callander, Navneet S. Majhail, Peter H. Wiernik, Rajneesh Nath, Rammurti T. Kamble, Ravi Vij, Robert A. Kyle, Robert Peter Gale, Parameswaran Hari

    Опубліковано 2011
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  10. 10
    Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation

    Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation за авторством Nina Shah, Natalie S. Callander, Siddhartha Ganguly, Zartash Gul, Mehdi Hamadani, Luciano J. Costa, Salyka Sengsayadeth, Muneer H. Abidi, Parameswaran Hari, Mohamad Mohty, Yi‐Bin Chen, John Koreth, Heather Landau, Hillard M. Lazarus, Helen Leather, Navneet S. Majhail, Rajneesh Nath, Keren Osman, Miguel‐Angel Perales, Jeffrey Schriber, Paul Shaughnessy, David H. Vesole, Ravi Vij, John R. Wingard, Sergio Giralt, Bipin N. Savani

    Опубліковано 2015
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  11. 11
    Salvage Second Hematopoietic Cell Transplantation in Myeloma

    Salvage Second Hematopoietic Cell Transplantation in Myeloma за авторством Laura C. Michaelis, Ayman Saad, Xiaobo Zhong, Jennifer Le‐Rademacher, César O. Freytes, David I. Marks, Hillard M. Lazarus, Jennifer M. Bird, Leona Holmberg, Rammurti T. Kamble, Shaji Kumar, Michael Lill, Kenneth R. Meehan, Wael Saber, Jeffrey Schriber, Jason Tay, Dan T. Vogl, Baldeep Wirk, Bipin N. Savani, Robert Peter Gale, David H. Vesole, Gary J. Schiller, Muneer H. Abidi, Kenneth C. Anderson, Taiga Nishihori, Matt Kalaycio, Julie M. Vose, Jan S. Moreb, William R. Drobyski, Reinhold Munker, Vivek Roy, Armin Ghobadi, H. Kent Holland, Rajneesh Nath, L. Bik To, Ângelo Maiolino, Adetola A. Kassim, Sergio Giralt, Heather Landau, Harry C. Schouten, Richard T. Maziarz, Joseph Mıkhael, Tamila L. Kindwall‐Keller, Patrick J. Stiff, John Gibson, Sagar Lonial, Amrita Krishnan, Angela Dispenzieri, Parameswaran Hari

    Опубліковано 2013
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  12. 12
    Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma

    Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma за авторством Robert F. Cornell, Anita D’Souza, Adetola A. Kassim, Luciano J. Costa, Racquel Innis-Shelton, Mei-Jie Zhang, Jiaxing Huang, Muneer H. Abidi, Jack Aiello, Görgün Akpek, Asad Bashey, Qaiser Bashir, Jan Černý, Raymond L. Comenzo, Miguel Ángel Díaz, César O. Freytes, Robert Peter Gale, Siddhartha Ganguly, Mehdi Hamadani, Shahrukh K. Hashmi, Leona Holmberg, Nasheed Hossain, Rammurti T. Kamble, Mohamed A. Kharfan‐Dabaja, Tamila L. Kindwall‐Keller, Robert A. Kyle, Shaji Kumar, Hillard M. Lazarus, Cindy Lee, Ângelo Maiolino, David I. Marks, Kenneth R. Meehan, Joe Mikhael, Rajneesh Nath, Taiga Nishihori, Richard F. Olsson, Muthalagu Ramanathan, Ayman Saad, Sachiko Seo, Saad Z. Usmani, David H. Vesole, Ravi Vij, Dan T. Vogl, Baldeep Wirk, Jean A. Yared, Amrita Krishnan, Tomer M. Mark, Yago Nieto, Parameswaran Hari

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: